Licensing deals

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Kyorin has strengthened its autoimmune portfolio by paying $10 million upfront for the Japan rights to Hinge Bio’s preclinical lupus drug.
James Waldron Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Gilead pumps up virology pipeline with drug transporter deal

Sep 29, 2025 10:35am
HPE conf

US biotechs thinking twice about licensing drugs to Europe

Sep 26, 2025 8:09am
research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Sep 25, 2025 7:00am
increase

Biopharma biobucks decline, while upfront deal payments rise

Sep 24, 2025 11:30am